[Prognostic factors related to remission duration and the effects of maintenance therapy in BHAC-DMP therapy in adult acute non-lymphocytic leukemia patients].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003843:Deoxycytidine Monophosphate / Q000008:administration & dosage; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008875:Middle Aged; D011379:Prognosis; D012044:Regression Analysis; D012074:Remission Induction
D003561:Cytarabine; D003843:Deoxycytidine Monophosphate; C015019:enocitabine